The Participants have the option of enrolling in one or more prevention studies over time. Compensation is provided for participants’ time and effort in each study. By enrolling in a clinical trial a participant has:

  • The chance to receive an experimental drug or treatment before it is widely available
  • The opportunity to receive regular medical attention at little or no cost
  • The satisfaction of contributing to scientific knowledge about the disease and improving existing treatments  

Network

“For Short”

Types of Research Studies

Eligible population

HIV Vaccine Trials Network

HVTN

HIV Prevention

HIV prevention vaccines

In good general health, HIV negative

Microbicide Trials Network

MTN

HIV Prevention

Products applied inside the vagina or rectum to prevent HIV transmisson. 

In good general health, HIV negative

HIV Prevention Trials Network

HPTN

HIV Prevention

Various strategies aimed at reducing HIV transmission & acquisition such as ART adherence, engagement in care, and PrEP (pre-exposure prophylaxis)

In good general health, HIV negative

HIV Prevention Studies


HVTN 133 is a phase I clinical trial open to HIV negative individuals looking to test the safety and immune response of an experimental HIV vaccine.



For more information or to see if you are elibile, please contact us via phone or the web.
    
 

HVTN 137 is a phase i clinical trial open to HIV negative individuals. To see if you are pre-eligible, call one of our recruiters at 205-934-6777.